Recent 2025-2026 reviews position tesamorelin in metabolic-dysfunction-associated-steatotic-liver-disease (MASLD) research (Gattu 2025, PMID 40397552) and in lean-mass-preservation research (Arora 2026, PMID 41598480)
doi: 10.1002/bab.2303 138 MehdizadehAKarimiEOskoueianE
Weve found real-life heroes in our community of women, and its time to share their stories, says Lauren Butler, the brands Head of Marketing
Alexandra Sowa, MD SoWell Founder Dual Board-Certified Obesity & Internal Medicine Physician Frequently Asked Questions What are FSA and HSA accounts
Retatrutide (LY3437943) is an investigational GLP-1, GIP, and glucagon triple receptor agonist currently in Phase 2 clinical trials
Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis